Listen to Gynecologic Oncology

Editor's Choice:  Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer
Editorial: Same-day discharge in advanced ovarian cancer as a milestone of surgical evolution and patient selection
Hosted by: 
Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta Canada
Featuring: 
Surabhi Tewari, MD, Department of Obstetrics and Gynecology, Mass General Brigham, Harvard Medical School, Boston, MA, USA
Alexander Melamed, MD MPH, Department of Obstetrics and Gynecology, Mass General Brigham, Harvard Medical School, Boston, MA, USA
Jose Alejandro Rauh-Hain, MD MPH, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement
Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Editor's Choice:  Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial
Editorial: Commentary on: Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup Canadian Cancer Trials Group Cx.5/SHAPE trial
Hosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta Canada

Featuring: Janice S. Kwon  MD, MPH, FRCSC, University of British Columbia, Vancouver, Canada and  R. Wendel Naumann, MD Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 28203, USA

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Editorial: Towards personalizing PARP inhibitor maintenance therapy for ovarian cancer
Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology

Featuring:
Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA
Christina M. Annunziata, American Cancer Society, Atlanta, GA, USA

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Editor’s Choice: Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approaches
Editorial: Who is following up? Rethinking survivorship and surveillance

Hosted by: Paola A Gehrig, MD University of Virginia Charlottesville, Virginia United States
Featuring:
Lee-may Chen, MD; Division of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States
Esther Vermaas; Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
J.W.M. Aarts, MD, PhD; Principal Investigator and Gynaecological oncologist Amsterdam University Medical Centers, location VUMC, the Netherland

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net